Gas phase studies of the interactions of Fe2+ with cysteine-containing peptides  by Nemirovskiy, Olga V & Gross, Michael L
Gas Phase Studies of the Interactions of Fe21
with Cysteine-Containing Peptides
Olga V. Nemirovskiy and Michael L. Gross
Department of Chemistry, Washington University, St. Louis, Missouri, USA
Gas-phase complexes of cysteine-containing peptides and Fe21 were produced by fast atom
bombardment and studied by tandem mass spectrometry. Specific and strong interactions of
the iron and sulfur from the thiol group of the cysteine side chain are preserved in the gas
phase and are the basis for highly specific fragmentation to give abundant [an 2 2H 1 Fe]
1
ions, where n is position of the cysteine residue from the N-terminus of peptide. Metal/
peptide complexes containing more than one Cys residue were also investigated; they display
similar chemistry upon collisionally activated decompositions, indicating that the Fe21 ion
primarily binds at cysteine sites. (J Am Soc Mass Spectrom 1998, 9, 1285–1292) © 1998
American Society for Mass Spectrometry
The function of iron-containing proteins is deter-mined by the properties of the metal center andits surrounding environment [1–5]. The struc-
tural, redox, and ligand-exchange properties of the iron
center can be strongly altered by the ligand field of the
coordination sphere [4]. High-spin octahedral ferrous
complexes are exchange labile, whereas the correspond-
ing axially ligated porphyrin complexes are spin paired
(diamagnetic) and inert to ligand exchange. Large,
bulky ligands, such as those provided by metallopro-
teins and enzyme sites, bind in a tetrahedral environ-
ment in which both Fe21 and Fe31 ions form high-spin
complexes. The most preferred ligands for tetrahedral
coordination are thiol groups such as those of a cysteine
side chain [6, 7]. Knowledge of the interactions of Fe21
ions with sulfur ligands and of the structures of the
resulting complexes is essential for understanding elec-
tronic structures and oxidation–reduction properties of
Fe21-containing proteins.
Often metal–ion binding sites are in the interior of
proteins and are composed of a number of side-chain
ligands that surround and interact simultaneously with
the metal ion. The specificity of metal–ion binding to
protein groups is determined by the intrinsic affinity of
the peptide ligands and by solvent effects. The study of
gas-phase metal-ion/peptide interactions, therefore, is
appropriate for dissecting solution properties into in-
trinsic and solvation effects.
We are investigating the gas-phase interactions of
metal ions with relatively low molecular weight pep-
tides that closely mimic biological ligands in terms of
composition, ligand types, and structure. We are inter-
ested in the study of metal/peptide complexes in the
gas phase because they provide not only an under-
standing of intrinsic effects but also a foundation for
new approaches to structure determination of peptides
[8–22]. Most recent efforts in this emerging mass spec-
trometric area have been directed at the interactions of
small peptides with alkali [8–13], alkaline-earth [14–
18], and transition metals [19–28].
We reported recently in a communication [29] that
specific and strong interactions of Fe21 ions with the
thiol groups of the Cys side chain are preserved in the
gas phase and lead to the formation of stable [M 2
H 1 Fe]1 complexes. CAD of these complexes resulted
in the formation of [an 2 2H 1 Fe]
1 fragment ions,
where n is position of Cys residue in the peptide chain.
This interesting finding motivated us to conduct further
investigations of the interactions of Fe21 ions with
cysteine-containing peptides. In this article, we show
that the complexes formed from a series of peptides
ranging from penta to decamers containing one or more
Cys at various positions decompose in highly specific
way and reveal the location of the Fe21 binding site.
Experimental
Reagents
The peptides used for this work were from the Immu-
nology Program, Department of Pathology, Washing-
ton University School of Medicine, and were prepared
by automatic stepwise solid-phase peptide synthesis
from Fmoc-protected amino acids. The crude peptides
were purified by reverse-phase high-performance liq-
uid chromatography (HPLC) by using a C-18 column,
and collected fractions were lyophilized. The identity of
the peptides was confirmed by fast-atom bombardment
(FAB) mass spectrometry and tandem mass spectrom-
etry of the [M 1 H]1 ions. A 1:1 mixture of glycerol and
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thioglycerol saturated with Fe(NO3)2 was used to pro-
duce the metal/peptide complexes. The reagents for the
matrix were obtained from Sigma (St. Louis, MO).
Instrumentation
Mass spectrometric experiments were performed on VG
ZAB-T (Manchester, UK), four-sector [30] and Kratos
MS-50, triple-sector mass spectrometers. The VG ZAB-T
tandem mass spectrometer consisted of two high-mass,
double-focusing mass spectrometers of overall BEBE
design. FAB mass spectra were acquired after adjusting
the mass resolving power of MS1 to approximately 1200
(10% valley definition). The instrument was operated at
an accelerating voltage of 8 kV. FAB was by a Cs1 gun
that provided a 30-keV Cs1 beam (the overall energy
for desorption was 22 keV). The second stage, which is
a reverse-geometry, Mattauch–Herzog type instrument
with a planar electrostatic analyzer, was used to obtain
product-ion mass spectra of precursor ions isolated by
MS1. Ions were activated by collisions with helium gas
at pressures sufficient to give 50% main-beam suppres-
sion; the collision cell was floated at 4 kV. The fragment
ions formed in the third-field-free region were detected
by a single-point detector. Data acquisition was carried
out with a VG OPUS V 3.1X data system, which was
interfaced to the mass spectrometer by means of a VG
SIOS I unit.
The Kratos MS-50 tandem mass spectrometer, which
was a forward geometry EBE instrument, was equipped
with a Kratos FAB ion source and an Ion Tech saddle-
field atom gun (Ion Tech, Middlesex, England), which
produced a 6-keV Ar atom beam for FAB desorption.
Collision cells were located in both field-free regions:
between ESA-1 and the magnet and between the mag-
net and ESA-2. For acquiring product-ion mass spectra,
MS-1 (ESA-1 and the magnet) were used to select the
precursor ion, and a mass-analyzed ion kinetic energy
scan (MIKES) was conducted by scanning the field of
ESA-2. When MS/MS/MS experiments were per-
formed, the ions (m1) produced in the source were
activated in the first collision cell, and a specific frag-
ment ion (m2) was selected by adjusting the ESA-1 to
E/E0 and the magnet to B/B0, where E is (m2/m1) 3
E0, B is (m2/m1) 3 B0, and E0 and B0 are electric and
magnetic-field strengths, respectively, of the precursor
ions (m1), allowing the ion of interest to be transmitted.
The CAD spectra then were recorded by scanning the
ESA-2. Helium was used as collision gas and was
introduced to a pressure sufficient to reduce the precur-
sor-ion beam by 50%.
Procedures
For acquiring both FAB full-scan and tandem mass
spectra, 1 mL of the matrix was mixed with 1 mL of a
1-mg/mL peptide solution. The probe was admitted to
the ion source and bombarded with the Cs1 or Ar atom
beam, depending on the instrument, to cause desorp-
tion. Usually, 10–20 scans were acquired and signal
averaged to obtain a mass spectrum of the product ions.
The deuterium-labeled peptides were prepared on
the FAB probe tip by using D2O (Sigma) as a solvent,
which was added to the mixture of the peptide and
iron-containing matrix. The volatile H2O, HDO, and
D2O were pumped away in the vacuum interlock of the
FAB source. To obtain nearly complete isotopic ex-
change, the procedure was repeated three times.
Four Fe21/peptide complexes of GCCAL, AVAGCL,
GCACLV, and GCACVCL were also formed by electro-
spray ionization and submitted to low-energy colli-
sional activation (LECA) on ion-trap instrument (Finni-
gan LCQ, San Jose, CA). The electrospray conditions for
the production of [M 2 H 1 Fe]1 were the same as for
the production of [M 1 H]1, except the carrier solution,
which was aqueous 0.2-mM FeCl2 instead of 50:50
H2O:MeOH. The samples were introduced at a flow
rate of 10 mL/min. The spray needle was held at 4.2 kV,
and a 70 lb/in.2 coaxial flow of nitrogen was used to
stabilize the spray. A heated (200 °C) stainless-steel
capillary served as the counterelectrode and was held at
13.5 V. In all experiments, helium was introduced to a
pressure of 1 mtorr (measured by a remote ion gauge)
for improving the trapping efficiency of the ion trap.
The background helium gas also served as the collision
gas. Collisional activation of the ions, which were
excited by a tickle voltage (20 V) applied to the end
caps, proceeded via multiple, low-energy collisions
with helium. The isolation width and time for the
collisional activation experiments were 1 u and 300 ms,
respectively.
Results and Discussion
We investigated the interaction of cysteine-containing
peptides with Fe21 by desorbing with FAB the peptide/
metal complexes into the gas phase as [M 2 H 1 Fe]1
species and then submitting the desorbed species to
collisional activation. For transition metal/peptide
complexes, the amino-acid side chains usually provide
the ligating atoms [25, 26, 29, 31, 32], although depro-
tonated nitrogens and carbonyl oxygens probably also
serve as ligands [17–20]. Sulfur is the preferred biolog-
ical ligand for Fe21.
Fragmentation of Iron/Peptide Complexes
Containing Hexa to Decapeptides
We showed previously [29] that Cys-containing pen-
tapeptides/iron complexes decompose upon CAD to
give abundant a*n ions, where n is the position of the
Cys residue with respect to the N-terminus of the
peptide backbone. The nomenclature we now use is a
simple adaption to the standard one for peptides. We
omit the metal from the labels and designate product
ions as if they were formed from protonated precursors;
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for example, ions that contain Fe21 are designated by an
* such that, an a*n ion is [an 2 2H 1 Fe]
1.
Here we ask the question whether gas-phase com-
plexes of Fe21 ions bound to the hexa, hepta, octa, and
decapeptides containing one Cys residue in the peptide
chain fragment in a manner that is consistent with that
of the pentapeptides [29]. If they do, then the iron/
peptide interaction may provide a general method to
indicate the location of a cysteine residue in a peptide.
Tandem mass spectrometry of FAB-produced ions re-
veals that strong and specific interactions of Fe21 ions
with the Cys side chain are preserved in the gas phase
for 20 additional peptides that contain six or more
amino acids (Table 1).
Just as Cys-containing pentapeptide/iron complexes
decompose upon CAD to give abundant a*n ions, so do
hexamers (e.g., VGACAL and AVAGCL) give a highly
specific fragmentation at the periphery of the Cys
residue to produce a*4 and a*5 ions of m/z 357 and 428,
respectively (Figure 1). The hexapeptides probably bind
Fe21 in the same tetrahedral fashion; that is, sulfur is the
primary binding ligand and nitrogens are the secondary
ligands. The simplicity of the CAD spectra of peptide/
iron complexes suggests that the number of fragmenta-
tion channels is significantly fewer than those of pro-
tonated peptides (compare Figure 1A, B with Figure
1C). Because protonation of peptides is not very spe-
cific, cleavages of the [M 1 H]1 ion of VGACAL are
typical and take place almost at every peptide bond to
give principally b and a and, to a lesser extent, y and v
sequence ions. The fragmentation channels for the de-
composition of [M 2 H 1 Fe]1 complexes, on the other
hand, are determined by the site of metal attachment
and are very specific. By providing a primary binding
site (an anchor) for the metal ion and secondary chela-
tion with amide nitrogens, the peptides strongly bind
Fe21, and all fragment ions retain the metal. Besides
sulfur ligands, other bonding atoms such as nitrogens
Table 1. Peptide sequence and major fragment ions for Fe21-binding studies
Sequence Major fragment ions
Peptides with one Cys residue
AVAGCL –H2O (a5 2 2H 1 Fe)
1
VGACAL –H2O (a4 2 2H 1 Fe)
1
AGVCAGV –H2O (a4 2 2H 1 Fe)
1
AGVACGV –H2O (a5 2 2H 1 Fe)
1
AGVAGCV –H2O (a6 2 2H 1 Fe)
1
AGVACGVL –H2O (a5 2 2H 1 Fe)
1
AGVAGCVL –H2O (a6 2 2H 1 Fe)
1
AGVAGVCL –H2O (a7 2 2H 1 Fe)
1
AGVAGVAGCL –H2O (a9 2 2H 1 Fe)
1
Peptides with two Cys residues
GCCAL –H2O (a3 2 2H 1 Fe)
1 (a3 2 2H 1 Fe 2 H2O)
1 –H2S
(a2 2 2H 1 Fe)
1
GCCAL-NH2 –H2O (a3 2 2H 1 Fe)
1 (a3 2 2H 1 Fe 2 H2O)
1 –H2S
(a2 2 2H 1 Fe)
1
AGCCAL –H2O (a4 2 2H 1 Fe)
1 (a4 2 2H 1 Fe 2 H2O)
1 –H2S
(a3 2 2H 1 Fe)
1
GAVCCL –H2O (a5 2 2H 1 Fe)
1 (a5 2 2H 1 Fe 2 H2O)
1 –H2S
(a4 2 2H 1 Fe)
1
GCACLV –H2O (a4 2 2H 1 Fe)
1 (a2 2 2H 1 Fe)
1 –H2S
ACGVCL –H2O (a5 2 2H 1 Fe)
1 (a2 2 2H 1 Fe)
1 –H2S
ACGVACL –H2O (a6 2 2H 1 Fe)
1 (a2 2 2H 1 Fe)
1 –H2S
Peptides with three Cys residues
GCACVC –H2O (a4 2 2H 1 Fe)
1 (a2 2 2H 1 Fe)
1 –H2S
GCACVCL –H2O (a6 2 2H 1 Fe)
1 (a4 2 2H 1 Fe)
1 –H2S
(a2 2 2H 1 Fe)
1
GCCACV –H2O (a5 2 2H 1 Fe)
1 (a3 2 2H 1 Fe 2 H2O)
1 –H2S
(a3 2 2H 1 Fe)
1
(a2 2 2H 1 Fe)
1
GCCCAV –H2O (a4 2 2H 1 Fe)
1 (a4 2 2H 1 Fe 2 H2O)
1 –H2S
(a3 2 2H 1 Fe)
1 (a3 2 2H 1 Fe 2 H2O)
1
(a2 2 2H 1 Fe)
1
Peptides with four Cys residues
GCCCCA –H2O (a5 2 2H 1 Fe)
1 (a4 2 2H 1 Fe 2 H2O)
1 –H2H
(a4 2 2H 1 Fe)
1 (a3 2 2H 1 Fe 2 H2O)
1
(a3 2 2H 1 Fe)
1
(a2 2 2H 1 Fe)
1
Peptides with no Cys residuesa
AAVGAVL –H2O x6, a6 y5, w5, c5, b5, a5 c4, b4, a4
aAll ions contain Fe21.
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are found in the iron–sulfur centers. An example is a
Rieske center [23], where two imidazole nitrogens, in
addition to the sulfur, are bound to the Fe atom. The
proposed structure for these centers is tetrahedral, as
was suggested for the sulfur–iron centers [23].
To verify that S serves as the anchor, a peptide
containing only amino acids with aliphatic side chains
(AAVGAVL) was studied. The full-scan FAB mass
spectrum of AAVGAVL desorbed from an Fe21-con-
taining matrix is dominated by the [M 1 H]1 ion of the
peptide, and the relative abundance of the [M 2 H 1
Fe]1 ion is less than 10%, whereas the iron/peptide
complexes and the [M 1 H]1 ions are of comparable
abundances for Cys-containing peptides [29]. If Fe21
has no preferential binding to the peptide, it will not
bind as well as the proton, and its weak binding will be
nonspecific, allowing many equally favorable Fe21/
peptide complexes to exist, each of which has its own
fragmentation pathways. This nonspecific binding of
Fe21 to the peptide results in more complicated CAD
spectra than those of Fe21-bound peptides containing
one or more cysteines (Figure 1D). Clearly the SH of
Cys is a principal binding site or anchor for gas-phase
Fe21. The evidence does not rule out, however, compet-
itive binding of Fe21 to other functional groups (e.g.,
OH, NH2).
Complexes of Fe21 with hepta, octa and decapep-
tides decompose in a fashion that is similar to that of
penta and hexapeptides. The expected a*n ions are
formed, but their abundances relative to that of the
precursor ion decreases as the Cys is moved toward
C-terminus (e.g., a*4 . a*5 . a*6). For heptapeptides
containing a Cys residue at position 6 from the N-
terminus, the abundance of the a*6 ion is two times
smaller than that of a*4 from a peptide with Cys at
position 4 (Figure 2). Formation of a* ions may be less
favorable for peptides with the Cys residue remote
from the N-terminus because the simultaneous interac-
tion of Fe21 with the terminal NH2 and the thiol group
of cysteine requires folding of the peptide backbone
around the metal center to give a macrocycle. This is
entropically less favorable than forming a complex
when the thiol group and the N-terminal NH2 are more
proximate.
Bonding of Fe21 to Peptides Containing Two or
More SH Groups
Upon CA, complexes of Fe21 with peptides of the
composition GCACLV and GCACVC decompose to
give abundant a*2 ions of m/z 187 and a*4 ions of m/z
360. These fragmentations of hexapeptides containing
two Cys that are separated by one residue are similar to
those reported for the pentapeptide GCACL [29]. The
modest extension of the chain from penta to hexapep-
tides does not cause any change in fragmentation
because the various ligand sites that bind to the metal
remain the same. Furthermore, incorporation of a third
Figure 1. The CAD mass spectra of [M 2 H 1 Fe]1 complexes of
peptides: (A) AVAGCL, (B) VGACAL (m/z 587), and (D) AAV-
GAVL (m/z 654) and CAD mass spectrum of [M 1 H]1 ion of (C)
VGACAL (m/z 533).
Figure 2. The CAD mass spectra of [M 2 H 1 Fe]1 complexes of
heptapeptides: (A) AGVAGCV, (B) AGVACGV, and (C) AGV-
CAGV (m/z 630).
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cysteine residue into the peptide at the C-terminus does
not affect the fragmentation scheme (Figure 3). This is
more evidence that the N-terminal amino group, in
addition to the SH group, is involved in bonding to
Fe21.
Peptides that contain cysteine residues remote to
each other (e.g., ACGVCL and ACGVACL) are less
prone to fragment to an a*n ion upon binding to the iron.
Facile water loss from the [M 2 H 1 Fe]1 ion is the
major fragmentation channel. Other low-abundance
ions are a*2 of m/z 201 for both iron/peptide complexes,
a*5 of m/z 460 for ACGVCL, and a*6 of m/z 531 for
ACGVACL. The relatively low abundance of a* ions for
these complexes, compared to those with one Cys
residue, suggest that both cysteine functional groups
are involved in the binding to the iron. Even though the
peptide backbone may be broken by “Cys-directed”
cleavage to give an a* ion, simultaneous interaction of
iron with the second cysteine holds the complex to-
gether. Multiple Cys-directed cleavages are required to
fragment the iron/peptide complex. Because multiple
cleavages are less probable and may require additional
activating collisions than can occur in a tandem four-
sector instrument, formation of these ions is not fa-
vored.
When the Cys residues adjoin each other, the frag-
mentation of iron/peptide complexes is similar to that
of peptides with two Cys residues that are separated by
one residue. The expected a*2 ions of m/z 187 and a*3 ions
of m/z 290 are produced for GCCAL, GCCACV,
GCCCAV, and GCCCCA peptides. An additional a*5
fragment ion of m/z 464 arises for the peptide
GCCACV, an a*4 ion of m/z 393 for the GCCCAV, and
a*4 of m/z 393 and a*5 of m/z 496 for the iron-bound
complex of GCCCCA (Figure 4). Besides the expected
iron-containing a ions, an ion [a*3 2 H2O] of m/z 272 is
produced upon CA of these peptides. These observa-
tions verify that Fe21/peptide interactions can be used
to indicate the locations of most cysteine residues in
peptides with multiple Cys residues, although the sig-
nal-to-noise ratios for some a*n ion signals are low.
Losses of Small Molecules from the Iron/Peptide
Complexes
The facile losses of small molecules such as H2O and
H2S occur upon CA of iron/peptide complexes. As was
reported by Hu et al. [17, 19], facile losses of side-chain
groups from metal–ion, complexes of peptides may
result from direct metal–ion, side-chain interactions.
Because the Cys thiol group is a reasonable base (proton
affinities of the cysteine residue and propanethiol are
214 [33] and 190 [34] kcal/mol, respectively), it can
accept a proton from the peptide backbone and be
released as H2S. Deuterium-labeling experiments show
that the loss from a metal/peptide complex in which all
active hydrogens are exchanged for D is 35 u, showing
loss of HDS. One hydrogen of the expelled H2S origi-
nates from a nonexchangable site and may involve the
transfer of an a-hydrogen from the peptide chain
through a four-membered ring intermediate (Scheme
1).
Figure 3. The CAD mass spectra of [M 2 H 1 Fe]1 complexes of
hexapeptides: (A) GCACVC (m/z 609) and (B) GCACLV (m/z
619).
Figure 4. The CAD mass spectra of [M 2 H 1 Fe]1 complexes of
peptides: (A) GCCAL (m/z 520), (B) GCCACV, (C) GCCCAV
(m/z 609), and (D) GCCCCA (m/z 613).
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To address mechanisms for water loss other than
that described previously [16], we carried out isotope
labeling experiments on the Fe21/complex of GCCAL.
Deuterium exchange of the active hydrogens of the
peptide shows that the [peptide-d9 2 D 1 Fe]
1 of m/z
528, decomposes to give product ions of m/z 508 and
509, indicating that there are two independent mecha-
nisms for the loss of H2O (Figure 5). A mechanism for
loss of HDO (formation of m/z 509 ion) was described
previously [16], and it involves the C-terminal OH
group and the nonexchangable a-hydrogen. The loss of
D2O shows the existence of a mechanism that depends
on the dramatic increases in the acidities of the amide
and thiol groups caused by binding to Fe21 [35]. In
solution, the acidity of a ligand amide group increases
(pKa decreases to 4.0) [35] owing to their participation
in multidentate chelation to Fe21. Crystal structures
reveal that complexation by the metal ion causes the
bond length of the peptide (C–N) bond to decrease and
to take on more double-bond character, whereas the
C–O bond lengthens and has less double-bond charac-
ter [35]. The peptide nitrogens that are bound to Fe21 do
not bear a proton according to their crystal structures
[35]. Rather, when peptide nitrogens are coordinated to
metal ions, protons are bound at the peptide oxygens.
This leads to the formation of enamides, tautomers of
the –CO–NH– bond, which in the gas phase, contribute
a proton to the departing water molecule. To gather
additional evidence, we submitted the iron/peptide
complex of GCCAL–NH2 to CA; the loss of water
remains a dominant fragmentation pathway, even in
the absence of a free carboxylic acid C-terminus.
Origin of the [a*n 2 H2O] Ions
A peak corresponding to the abundant ion [a*3 2 H2O]
of m/z 272 is in all the spectra of peptides with two
adjacent Cys residues located in positions 2 and 3 from
the N-terminus. The process giving rise to this ion
appears to be general because Fe21/peptide complexes
that contain two Cys residues at positions 3 and 4,
decompose to give [a*4 2 H2O] ions, and those with two
Cys residues at positions 4 and 5 produce [a*5 2 H2O]
ions. Furthermore, both [a*3 2 H2O] and [a*4 2 H2O] ions
were formed when the Fe21/GCCCAV complex was
submitted to CA. The abundance of the [a*5 2 H2O] ion
is much lower than that of the [a*3 2 H2O], probably
owing to the participation of the N-terminal NH2 in ion
formation.
To investigate the origin of the m/z 272 ion, we
carried out higher order (MS3) collisional activation and
isotope-labeling experiments. CAD of the product ion
of m/z 502, which is [M 2 H 1 Fe 2 H2O]
1 of GCCAL,
gives rise to the fragment ions of m/z 484, [M 2
H 1 Fe 2 2H2O]
1, m/z 361, a*4 2 H2O, and m/z 272, a*3
2 H2O. Subsequent activation of the m/z 290 ion (in an
MS3 experiment), which is a*3 and comes from the
original complex, leads to the formation of the low
abundance ion a*2 of m/z 187 and [a3 2 2H 1
Fe 2 H2O]
1 of m/z 272. The ion of m/z 272 is formed
from that of m/z 502, [M 2 H 1 Fe 2 H2O]
1 by se-
quential reaction at the site of the Cys that is involved in
binding to Fe21 and from the ion a*3 undergoing H2O
loss (Scheme 2).
Low-Energy CAD of ESI-Produced [M 2 H 1 Fe]1
Ions
[M 2 H 1 Fe]1 ions can be formed by electrospray
ionization (ESI) as well as by FAB, and their abundance
is a major fraction of that of the [M 1 H]1. We studied
four peptides GCCAL, AVAGCL, GCACLV, and
GCACVCL and found that none gave the characteristic
a*n ions that indicate the location of Cys. The most facile
fragmentation instead is loss of H2O for all peptides,
and, for those containing two or more Cys, a second loss
of water. The only sequence ions are (bn21)* and
[(bn21)* 2 H2O], where n is the number of amino acids
in the peptide. Clearly, different fragmentation chan-
Scheme 1
Figure 5. The CAD mass spectrum of [M-d9 2 D 1 Fe]
1 complex
of GCCAL (m/z 528).
Scheme 2
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nels are available for [M 2 H 1 Fe]1 ions that are
activated by many low-energy than by a few high-
energy collisions. This difference may be because of
electronic excitation of the metal center upon high-
energy CA. Because our interest in this research is the
production of a* ions, we did not pursue low-energy
CA any further.
Conclusion
Specific and strong interactions of Fe21 with the thiol
group of Cys-containing peptides and with amide and
amine nitrogens occur in the gas phase. Owing to these
strong interactions, Fe21-containing complexes princi-
pally fragment upon high-energy CA to give a*n ions
that form at the sites of the cysteine residue. The
product ions are stabilized and resistant to further
fragmentation because the Fe–S interaction is preserved
in the fragmentation. Deprotonation of the amide and
thiol hydrogens occurs upon chelation to the Fe21
center, explaining the extensive water loss involving the
protonated carbonyl oxygen of the peptide bond in
addition to the more expected expulsion of water from
the unbound C-terminal carboxylic group.
The presence of more than one Cys residue in the
peptide chain causes additional [a*n 2 H2O] ions to form
upon CA of Fe21/peptide complexes. The effect de-
pends on the location of the cysteines with respect to
each other and, to a smaller extent, on the length of the
peptide chain. Peptides that contain adjacent Cys
(GCCAL, GCCACV, GCCCAV, and GCCCCA) form
complexes that decompose to give a series of metal-
containing a ions, depending on the position of Cys.
Future studies will consider larger peptides, pep-
tides with Cys at the N-terminus, and peptides with
other functional groups in addition to SH.
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